Publication | Closed Access

Ultra-low exposure to alpha-7 nicotinic acetylcholine receptor partial agonists elicits an improvement in cognition that corresponds with an increase in alpha-7 receptor expression in rodents: implications for low dose clinical efficacy

NeuropsychologyMedicineNicotinePharmacologyPsychopharmacologyNeuropharmacologyUltra-low ExposureNeuroscienceAlpha-7 Receptor ExpressionCognitive NeuroscienceNeurochemistrySocial Sciences